Cost-containment protocols for prostate core needle biopsies: hypothetical scenarios to reduce procedural costs
Background: In recent years, anatomic pathology laboratories have been struck by new revenue policies secondary to the Affordable Care Act. In particular, modifications to compensation for processing prostatic core needle biopsies (PCNBs) have led to important reimbursement cuts. Herein, we explore...
Main Authors: | Roberto Ruiz-Cordero, Alia Gupta, Andre Pinto, Merce Jorda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Prostate International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888217301642 |
Similar Items
-
Histopathologic Review of Previously Negative Prostatic Core Needle Biopsies following a New Diagnosis of Adenocarcinoma of the Prostate by Core Needle Biopsies: Implications for Quality Assurance Programs
by: Jay Patel, et al.
Published: (2008-01-01) -
Synchronously performed prostatic fine needle aspiration and core biopsies--an appraisal.
by: Prabhu G, et al.
Published: (1994-04-01) -
BREAST CORE NEEDLE BIOPSY
by: Reni Widyastuti, et al.
Published: (2013-03-01) -
Diagnostic Value of ERG in Prostate Needle Biopsies Containing Minute Cancer Foci
by: Bachurska Svitlana Y., et al.
Published: (2017-03-01) -
Transrectal ultrasound and needle biopsy of the prostate
by: Tomaž Smrkolj
Published: (2016-01-01)